The Developmental Brain Disorders Database (DBDB): A curated neurogenetics knowledge base with clinical and research applications

The number of single genes associated with neurodevelopmental disorders has increased dramatically over the past decade. The identification of causative genes for these disorders is important to clinical outcome as it allows for accurate assessment of prognosis, genetic counseling, delineation of natural history, inclusion in clinical trials, and in some cases determines therapy. Clinicians face the challenge of correctly identifying neurodevelopmental phenotypes, recognizing syndromes, and prioritizing the best candidate genes for testing. However, there is no central repository of definitions for many phenotypes, leading to errors of diagnosis. Additionally, there is no system of levels of evidence linking genes to phenotypes, making it difficult for clinicians to know which genes are most strongly associated with a given condition. We have developed the Developmental Brain Disorders Database (DBDB: https://www.dbdb.urmc.rochester.edu/home), a publicly available, online‐curated repository of genes, phenotypes, and syndromes associated with neurodevelopmental disorders. DBDB contains the first referenced ontology of developmental brain phenotypes, and uses a novel system of levels of evidence for gene‐phenotype associations. It is intended to assist clinicians in arriving at the correct diagnosis, select the most appropriate genetic test for that phenotype, and improve the care of patients with developmental brain disorders. For researchers interested in the discovery of novel genes for developmental brain disorders, DBDB provides a well‐curated source of important genes against which research sequencing results can be compared. Finally, DBDB allows novel observations about the landscape of the neurogenetics knowledge base. © 2014 Wiley Periodicals, Inc.

[1]  L. Shaffer,et al.  American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation , 2005, Genetics in Medicine.

[2]  Deborah A Nickerson,et al.  A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. , 2009, Genome research.

[3]  Gregory M. Cooper,et al.  A Copy Number Variation Morbidity Map of Developmental Delay , 2011, Nature Genetics.

[4]  S. Schelling,et al.  Pediatric neuroimaging. , 1994, Seminars in veterinary medicine and surgery.

[5]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[6]  B. Wilson.  The Challenge of Developing Evidence-Based Genetics Health Care in Practice , 2005, Familial Cancer.

[7]  J. Rivière,et al.  Megalencephaly Syndromes and Activating Mutations in the PI3K‐AKT Pathway: MPPH and MCAP , 2013, American journal of medical genetics. Part C, Seminars in medical genetics.

[8]  Wei Zheng,et al.  Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. , 2011, The Lancet. Oncology.

[9]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[10]  R. Kuzniecky,et al.  A developmental and genetic classification for malformations of cortical development: update 2012 , 2012, Brain : a journal of neurology.

[11]  Timothy W. Yu,et al.  Whole-Exome Sequencing and Homozygosity Analysis Implicate Depolarization-Regulated Neuronal Genes in Autism , 2012, PLoS genetics.

[12]  C. Walsh,et al.  Mutations in PNKP cause microcephaly, seizures and defects in DNA repair , 2010, Nature Genetics.

[13]  G. Arbanas.  Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .

[14]  C. Marra,et al.  Parental perceived value of a diagnosis for intellectual disability (ID): A qualitative comparison of families with and without a diagnosis for their child's ID , 2009, American journal of medical genetics. Part A.

[15]  Jay Shendure,et al.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2012, Nature Genetics.

[16]  Monique M. Ryan,et al.  Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration , 2012, Nature Genetics.

[17]  Richard M Myers,et al.  Population analysis of large copy number variants and hotspots of human genetic disease. , 2009, American journal of human genetics.

[18]  M. Gingold,et al.  CME Practice parameter : Evaluation of the child with global developmental delay , 2003 .

[19]  R. Kuzniecky,et al.  A developmental and genetic classification for malformations of cortical development , 2005, Neurology.

[20]  J. Moeschler.  Genetic evaluation of intellectual disabilities. , 2008, Seminars in pediatric neurology.

[21]  B. Haynes.  Of studies, syntheses, synopses, summaries, and systems: the "5S" evolution of information services for evidence-based healthcare decisions. , 2006, Evidence-based nursing.

[22]  H. Firth,et al.  Oxford Desk Reference Clinical Genetics , 2005 .

[23]  C. Panayiotopoulos.  A Clinical Guide to Epileptic Syndromes and Their Treatment, 2nd ed. , 2002, American Journal of Neuroradiology.

[24]  S. Teutsch,et al.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group , 2009, Genetics in Medicine.

[25]  Roger Weis,et al.  A Clinical Guide to Epileptic Syndromes and their Treatment , 2004 .

[26]  Sheng Wang,et al.  Lynx: a database and knowledge extraction engine for integrative medicine , 2013, Nucleic Acids Res..

[27]  Inanç Birol,et al.  Hive plots - rational approach to visualizing networks , 2012, Briefings Bioinform..